Tony Hunter, Brian Druker and John Mendelsohn have won this year’s Tang Prize in biopharmaceutical science for their breakthroughs in developing targeted cancer therapies, the Tang Prize Selection Committee announced yesterday.
Their research and findings of protein tyrosine phosphorylation and tyrosine kinases as oncogenes have led to successful targeted cancer therapies, the committee said.
The three winners, all Americans, have shown how basic science can lead to clinical applications that benefit humankind, said Chang Wen-chang (張文昌), a member of Academia Sinica and the convener of the selection committee.
Photo: CNA
Hunter demonstrated that a mechanism called tyrosine phosphorylation acts as a master on/off switch for a number of key proteins that are critical for successful cancer therapies, the committee said.
Hunter, a professor of biology at the Salk Institute, gave birth to the field of targeted therapies after discovering in 1979 the mechanism of tyrosine phosphorylation and that the oncogene Src is a tyrosine kinase.
The historic discovery paved the way for active research in the following two decades on tyrosine kinase oncogenes, ultimately leading to the development of tyrosine kinase inhibitors (TKIs).
Based on Hunter’s discovery, Druker, the director of Oregon Health & Science University’s Knight Cancer Institute, led the successful clinical trial of a cancer-fighting drug called imatinib.
The drug turned chronic myelogenous leukemia, a cancer that once had a very low survival rate, into a manageable condition.
Gleevec, a brand of imatinib, shuts off oncogenic signals by inhibiting Abl-protein tyrosine kinases as predicted by Hunter’s original research, the committee said.
Gleevec has also been successfully used in the treatment of acute lymphocytic leukemia and certain types of gastrointestinal stromal tumors by inhibiting other tyrosine kinase oncoproteins.
There are more than 26 TKIs that have been approved for clinical use. All of the discoveries have Druker’s first successful trials to thank because they spurred this still burgeoning targeted therapy era, the committee said.
John Mendelsohn, president emeritus of MD Anderson Cancer Center, took another approach to combating cancer.
An alternative way of shutting off the activities of tyrosine kinases on the cell surface (receptor tyrosine kinase) is to develop antibodies against the extracellular domain of the receptor, the committee said.
In such a way, the natural ligand, or growth factor, can no longer bind and the receptor tyrosine kinase is no longer activated. Mendelsohn and his team came up with the idea that antibodies targeting the epidermal growth factor receptor (EGFR) may be an effective strategy for cancer treatment.
Mendelsohn led his team in conducting preclinical research and proceeded to develop the anti-EGFR antibody cetuximab, which eventually won the US Food and Drug Administration’s approval for the treatment of colon cancer and head/neck cancer.
NATURE TAKES ITS COURSE: The agency’s head said he felt a sense of loss watching red-banded snakes eat the babies, as they had decided on non-intervention The Forestry and Nature Conservation Agency yesterday released a documentary on a hundred-pace viper that had incubated 16 eggs, all of which hatched, but only a baby viper escaped after they were attacked by red-banded snakes. The agency’s Taichung branch last year launched the viper reproduction monitoring project soon after forest rangers Lin Chun-yu (林俊佑) and Chou Chia-cheng (周家成) spotted a pregnant hundred-pace viper in a grass-covered burrow near a parking lot in Tbulan Village (松鶴部落). The Atayal village, in Taichung’s Heping District (和平), is headed by Ecyang Yapu, who was positive about the project and assisted in access control and power
The Coast Guard Administration (CGA) yesterday said that it had deployed vessels to “monitor” Chinese ships operating in waters off the east coast. The CGA said it dispatched vessels in response to a China Coast Guard announcement that it had carried out another “routine law-enforcement patrol” in waters off the east coast. “The CGA firmly rejects China’s cognitive warfare campaign of ‘law enforcement in name, jurisdictional expansion in practice,’” it said on X. As of 11am yesterday, two China Coast Guard ships were “loitering and drifting” about 105 nautical miles (195km) and 74 nautical miles east of Green Island (綠島) respectively, it said. It
A sharp rise in compensation to be paid by air force officers who leave before completing their required service could indicate an increase in pilots leaving the military early, an analyst said on Friday, warning that the trend could worsen a shortage of experienced personnel. Chieh Chung (揭仲), a researcher at the Association for Strategic Foresight, issued the warning even though the number of volunteer military personnel is expected to increase next year. The planned headcount for volunteer military personnel, covering officers, noncommissioned officers (NCO) and enlisted soldiers, is 158,223 for next year, up 4,258 from 153,965 this year, Chieh said. The increase
Potential improvements to munitions used by China’s long-range rocket-artillery units could extend their range to cover the entire Miyako Strait, which might give the Chinese People’s Liberation Army (PLA) the ability to secure the strategic waterway, the Mainland Affairs Council (MAC) said in a report. The PLA’s long-range rocket-artillery units deployed along the Taiwan Strait are concentrated along the coast of Fujian Province, including Changle, Pingtan and Shishi, the quarterly report on China said. The artillery brigades of the PLA’s 71st, 72nd and 73rd group armies have been deployed, with preparations for potential battlefield operations under way since August 2022, the report
RSS